Additionally, a small fraction (3–4%) of the gastric and lung cancer patients shows PPME1 gene amplification, which also corresponds to elevated PME‐1 protein expression and activation of ERK and AKT survival signaling 14. This evidence concerns the gene PPME1 and lung cancer.